Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Stem cells have a strong potential in developing better diagnostic, treatment and preventive strategies in SARS-CoV-2 infection. Both hematopoietic and mesenchymal stem cells are critical to better understand the response of immune system to coronavirus infection in both healthy and co-morbid conditions in the development of effective vaccines and immunotherapies.
Stem Cells and COVID-19 presents up-to-date knowledge on the effect of hematopoietic and mesenchymal stem cells to combat SARS-CoV-2 infection in its diagnosis, treatment and prevention, critically discuss the challenges, highlight outstanding questions and future perspectives. Written by global experts in the field for both pre-clinical and clinical practitioners.
- Focuses on diagnosis, treatment and prevention
- Presents different aspects to enable researchers in the field to move toward designing novel therapeutics in the treatment of COVID-19
- Provides coverage of the challenges and future perspectives in this fast-moving field
Researchers in universities, various translational research laboratories, pharma industries and also graduate students
2. Characteristics and Immunobiology of COVID19
3. Molecular Mechanism and translation approaches
4. Inflammatory multisystem syndrome in COVID19: Insights on off-target organ system in susceptible and recovering population
5. Cytokine storm and stem cell activation in unveiling potential targets for diagnosis and therapy
6. Mesenchymal and hematopoietic stem cells: Novel avenues in combating COVID19
7. Immunomodulatory properties of mesenchymal and hematopoietic stem cells – potential therapeutic target for COVID-19
8. COVID19 and acute myocardial injury: Stem cell driven tissue remodeling in COVID19 infection
9. Stem cell born signals and tissue regeneration in COVID19 infection
10. Stem cell transplantation COVID19 management: Translational possibilities and future
11. Therapeutic scale stem cell-derived exosomes for COVID - 19: Models – Validation, Management & Strategies
12. Therapy: present & future clinical perspective
- No. of pages:
- © Academic Press 2022
- 2nd May 2022
- Academic Press
- Paperback ISBN:
Dr. Chandra P. Sharma is former Senior Scientist G and Head, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum and has been Head, Biosurface Technology Division, SCTIMST, Trivandrum from January 1980 to February 2014. He has also been Associate Head, Biomedical Technology Wing, and Associate Dean, PhD Affairs, SCTIMST Trivandrum. Presently he is Adjunct Professor, Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal University. His basic activities relate understanding of blood/tissue – material interactions at the interface. In case of chitosan, an encouraging wound healing material, his group demonstrated during 1990s that its hemostatic potential is independent of classical coagulation cascade and appears to be an interaction between the cell membrane of erythrocytes and chitosan. His research interests include: biomaterials and artificial organs and nano-systems for oral delivery of insulin.
Adjunct Professor, Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka, India
Dr. Devendra K. Agrawal moved to Canada and earned PhD (Medical Sciences) in 1984 from McMaster University, Canada followed by a Postdoctoral Fellowship at the University of British Columbia, Vancouver, Canada. In 1985, he was recruited as an Asst Professor at Creighton University School of Medicine, Omaha, Nebraska where he rose to the rank of Full Professor in 1997. Dr. Agrawal also earned MBA in 2004 and MS in 2005 from Creighton University. In 2009, Dr. Agrawal founded the Center for Clinical & Translational Research at Creighton University, which later developed into an independent Department. Dr. Agrawal was the Founding Chairman of this Department. Dr. Agrawal also served as the Senior Associate Dean of Clinical & Translational Sciences at Creighton. In July 2019, he moved to California as Senior Vice President for Research and Professor of Translational Research at the Western University of Health Sciences, Pomona, CA.
Senior Vice President for Research and Professor, Translational Research, Western University of Health Sciences, Pomona, California, USA
Dr. Finosh Thankam is an assistant professor and researcher in Tissue Engineering and Regenerative Medicine, in the Department of Translational Research, at the Western University of Health Sciences, in Pomona, CA. His undergraduate studies were in Biochemistry, before completing his post-graduate degree in Medical Biochemistry from Mahatma Gandhi University, in India. As a research fellow he was exposed to the new world of tissue engineering and regenerative medicine and published many original articles on various aspects of cardiac tissue engineering. His current research interests include investigating the pathogenesis of various musculoskeletal disorders, and cardiovascular diseases, and applying the knowledge and principles of tissue engineering to develop artificial tissue constructs to improve the care for the sufferers.
Assistant Professor, Tissue Engineering and Regenerative Medicine, Department of Translational Research, Western University of Health Sciences, Pomona, California, USA
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.